Results 71 to 80 of about 115,025,331 (252)

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome [PDF]

open access: yes, 2011
Background Our objective was to find single nucleotide polymorphisms (SNPs), within transcriptional pathways of glucose and lipid metabolism, which are related to multiple features of the metabolic syndrome (MetS).
Boer, J.M.   +14 more
core   +1 more source

Engineering Microbial Particles for Next‐Generation Biomedical Platforms

open access: yesAdvanced Science, EarlyView.
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li   +7 more
wiley   +1 more source

Lipoprotein(a) and atherosclerosis

open access: yesАтеросклероз, 2007
Lp(a) lipoprotein is one of atherogenic forms of lipoproteins, it was discovered over 45 years ago. Lp(a) is a quantitative feature, its concentration being under polygenic control.
A. V. Tikhonov
doaj  

Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems

open access: yesBiomolecules
Changes in hepatic lipoprotein metabolism are responsible for the majority of metabolic dysfunction-associated disorders, including familial hypercholesterolemia (FH), metabolic syndrome (MetS), metabolic dysfunction-associated fatty liver disease (MAFLD)
Izabella Kiss   +5 more
doaj   +1 more source

Bioengineered Exosome‐Loaded Immunomodulatory Bioadhesive Spray Reverses Liver Fibrosis and Metabolic Dysfunction That Triggers Beneficial Gut‐Liver Crosstalk in Chronic Fatty Liver Disease

open access: yesAdvanced Science, EarlyView.
Umbilical cord stem cell‐derived exosomes encapsulated in an immunomodulatory bioadhesive hydrogel spray enable localized therapy, sustained vesicle delivery, macrophage polarization, suppress systemic inflammation, and mitigate glucose and insulin homeostasis impairments in MAFLD.
Triya Saha   +4 more
wiley   +1 more source

Dynamics of lipoprotein metabolism in adult growth hormone deficiency

open access: yes, 1999
Dyslipidaemia is often associated with adult growth hormone (GH) deficiency. Reduced removal of very-low-density lipoprotein (VLDL) apolipoprotein B-100 (apo B-100) can, in part, explain the "unfavourable" lipid profile of these patients.
Cummings, M H   +4 more
core   +1 more source

Differential effects of interferon-γ on metabolism of lipoprotein immune complexes mediated by specific human macrophage Fcγ receptors

open access: yesJournal of Lipid Research, 2000
: The objectives were to determine whether there are differences in the mechanisms of lipoprotein metabolism associated with different FcγRs and how metabolism associated with FcγRs compares to that mediated by scavenger receptors (SRA).
Peter M. Morganelli   +2 more
doaj   +1 more source

Epidemiological Study of Lipoprotein (a) in Okinawa [PDF]

open access: yes, 1995
A study of serum levels of lipoprotein (a) (Lp (a)) was performed among 217 normal adults including 135 men and 82 women in the northern part of Okinawa. Ages of the subjects ranged from 24 to 76 with an average of 49 years.
Tamamoto, Tohru   +5 more
core  

Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism

open access: yes, 2020
The autonomic regulation of hepatic metabolism offers a novel target for the treatment of non-alcoholic fatty liver disease (NAFLD). However, the molecular characteristics of neurons that regulate the brain-liver axis remain unclear.
Ivan Rudenko   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy